The first long-term study of Pfizer’s Covid-19 vaccine is out — and the results show that the shot is 100% effective against the coronavirus in those 12 to 15 years of age, it was announced on Monday.
Officials from Pfizer and BioNTech announced that their Covid-19 inoculation was 100% effective in preventing infections in adolescents in this age bracket, as seen from the results up to four months after administration of the second shot.
The results, from the Phase 3 trials of the Pfizer product, using a total of 2,228 subjects, will be used in the Pharma giant’s application to the US Food and Drug Administration for an extension of their Covid-19 vaccine authorization for that age cohort.
previous post